In vitro suppression of porcine epidemic diarrhea virus by Panax notoginseng saponins: assessing antiviral potential

• Published in: Archives of virology 2024-05, Vol.169 (5), p.89-89
• Main Authors: Hu, Yiyi, Li, Yunchuan, Zhu, Haodan, Wang, Dandan, Zhou, Junming, Ni, Yanxiu, Guo, Rongli, Fan, Baochao, Li, Bin
• Format: Article
• Language: English
• Subjects: Animals; Antiviral agents; Antiviral Agents - pharmacology; Biomedical and Life Sciences; Biomedicine; Chlorocebus aethiops; Cholecystokinin; Complement factor H; Coronavirus Infections; Cytotoxicity; Diarrhea; DNA damage; Enzyme-linked immunosorbent assay; Epidemics; Fatty acid-binding protein; Gadd45A protein; Genomes; Immunofluorescence; Infectious Diseases; Interferon; Interferons; Interleukin 1; Medical Microbiology; Neonates; Original Article; Panax notoginseng; Phospholipase C; Porcine epidemic diarrhea virus - genetics; Protein-tyrosine-phosphatase; Proteins; Saponins; Saponins - pharmacology; Suckling behavior; Swine; Swine Diseases - drug therapy; Transmissible gastroenteritis; Tumor necrosis factor receptors; Vero Cells; Virology; Viruses
• ISSN: 0304-8608; 1432-8798
• DOI: 10.1007/s00705-024-06020-8

Porcine epidemic diarrhea virus (PEDV) causes severe diarrhea and high mortality in neonatal suckling piglets, leading to significant economic losses to the swine industry. Panax notoginseng saponins (PNS) are bioactive extracts derived from the P. notoginseng plant. In this study, we investigated the anti-PEDV effect of PNS by employing various methodologies to assess their impact on PEDV in Vero cells. Using a CCK-8 (Cell Counting Kit-8) assay, we found that PNS had no significant cytotoxicity below the concentration of 128 µg/mL in Vero cells. Using immunofluorescence assays (IFAs), an enzyme-linked immunosorbent assay (ELISA), and plaque formation assays, we observed a dose-dependent inhibition of PEDV infection by PNS within 24–48 hours postinfection. PNS exerts its anti-PEDV activity specifically at the genome replication stage, and mRNA-seq analysis demonstrated that treatment with PNS resulted in increased expression of various genes, including IFIT1 (interferon-induced protein with tetratricopeptide repeats 1), IFIT3 (interferon-induced protein with tetratricopeptide repeats 3), CFH (complement factor H), IGSF10 (immunoglobulin superfamily member 10), ID2 (inhibitor of DNA binding 2), SPP1 (secreted phosphoprotein 1), PLCB4 (phospholipase C beta 4), and FABP4 (fatty acid binding protein 4), but it resulted in decreased expression of IL1A (interleukin 1 alpha), TNFRSF19 (TNF receptor superfamily member 19), CDH8 (cadherin 8), DDIT3 (DNA damage inducible transcript 3), GADD45A (growth arrest and DNA damage inducible alpha), PTPRG (protein tyrosine phosphatase receptor type G), PCK2 (phosphoenolpyruvate carboxykinase 2), and ADGRA2 (adhesion G protein-coupled receptor A2). This study provides insights into the potential mechanisms underlying the antiviral effects of PNS. Taken together, the results suggest that the PNS might effectively regulate the defense response to the virus and have potential to be used in antiviral therapies.